Current Employment Position(s)

Associate

Languages

• English
• German

Lawyer Overview

Tom Ritter has been working in intellectual property law since 2003 and was admitted to practice as a European Patent Attorney in 2006. Before joining Jones Day, he was an associate in the firm of Vossius & Partner in Munich. Tom advises clients in all areas of chemistry as well as in neighboring fields, particularly life sciences. Tom's experience includes drafting and prosecuting German, European, and international (PCT) patent applications in addition to representation in subsequent opposition proceedings. He also provides patentability, validity, freedom-to-operate, and infringement opinions and is involved in nullity and infringement proceedings.

Tom studied chemistry and biochemistry in Germany and in the United States. For his Ph.D. thesis, he explored different routes towards the inhibition of bacterial transglycosylase, synthesizing a new class of thiazolines as well as a library of vancomycin analogs. In this context, he participated in the development of a programmable one-pot method for the synthesis of oligosaccharides.

Areas of Practice

• Intellectual Property
• Patent Prosecution
• Patent Litigation
• Life Sciences
• Pharmaceuticals

West Practice Categories

Copyrights, Intellectual Property Law, International Intellectual Property, Patent Litigation, Patents, Technology Licensing, Trade Dress, Trade Secrets, Trademarks

Published Works

• Acceptor Specificity and Inhibition of the Bacterial Cell Wall Glycosyltransferase MurG, ChemBioChem 4 (2003) 603-609, 2003
• A Programmable One-Pot Oligosaccharide Synthesis for Diversifying the Sugar Domains of Natural Products: A Case Study of Vancomycin, Angewandte Chemie, Int. Ed. Engl. 42 (2003) 4657-4660, 2003
• Carbohydrate-Based Drug Discovery in the Battle Against Bacterial Infections; New Opportunities Arising from Programmed One-Pot Oligosaccharide Synthesis, Carbohydrate-Based Drug Discovery, Editor: Chi-Huey Wong, 2003, Wiley-VCH, Weinheim, 2003
• Synthesis of N-Acetylglucosamine Thiazoline/Lipid II Hybrids, Tetrahedron Letters 42 (2001) 615-618, 2001
• Carbohydrate-based Antibiotics: A New Approach to Tackling the Problem of Antibiotic Resistance, Angewandte Chemie, Int. Ed. Engl. 40 (2001) 3508-3533, 2001

Address

Prinzregentenstr. 11
80538 Munich, Federal Republic of Germany

Phones

49.89.20.60.42.200 (Business Phone)

Faxes

49.89.20.60.42.293 (Business Fax)

Emails

Contact Us (Business Email)

Websites

http://www.jonesday.com